Zhu Meiling, president of Shenzhen Hospital of Traditional Chinese Medicine, visited Shenzhen Cell Valley
On the afternoon of March 7, 2024, Zhu Meiling, President of Shenzhen Hospital of Traditional Chinese Medicine, Chen Sheng, Director of Oncology, Yang Zhenjiang, Director of Respiratory, Xie Wei, Director of splenic and Gastric, Guo Shaoju, Director of GCP Office, Liu Yu and others visited Shenzhen Cell Valley. Shi Yuanyuan, Chairman of our company, Wang Jianxun, chief scientist, and Tang Xiaomeng, deputy general Manager of our company received them warmly.
First of all, the leaders of Shenzhen Hospital of Traditional Chinese Medicine, accompanied by Professor Shi Yuanyuan, visited the smart exhibition hall, production workshop and research and development laboratory, and initially understood the development background, enterprise strength, product pipeline and planning layout of Shenzhen Cell Valley and its subsidiaries.
At the symposium, Professor Shi Yuanyuan warmly welcomed the arrival of President Zhu Meiling and Vice President Chen Sheng. Sun Rui, Director of the Marketing Department, elaborated on Shenzhen Cell Valley's core technologies, innovations and clinical success cases in cell and gene therapy. Shi Yuan said that Shenzhen Cell Valley, as a one-stop cell gene therapy solution provider, can provide customers with professional and efficient one-stop whole industry chain services from early research and development, carrier design, virus production, cell production to auxiliary declaration, and give full play to the advantages of retroviral vectors in the industrialization of cell therapy drugs. It provides innovative ideas for the promotion of basic research and clinical treatment, and provides epoch-making programs for the treatment of cancer and rare diseases. Dean Zhu Meiling highly affirmed the achievements made by Shenzhen Cell Valley in scientific research and clinical practice, and said that cell therapy, as an emerging modern biomedical technology, has promoted the treatment reform represented by precision medicine and provided a new strategy for the treatment of various diseases such as tumors. If traditional Chinese medicine and cell therapy are combined to play a synergistic role, It can be further applied in clinic by improving the therapeutic effect of cell therapy and alleviating the adverse reactions.
The two sides conducted in-depth exchanges on the combination of traditional Chinese medicine and modern medicine, joint project declaration and the construction of traditional Chinese medicine cell therapy platform, laying a good foundation for the follow-up joint clinical research, and working together to provide patients with more high-quality, accurate and efficient medical services.
